Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin

    October 2022 in “ Current Dermatology Reports
    Rhea Singh, Esther E. Freeman
    Image of study
    TLDR COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.
    The review discusses the various skin reactions following SARS-CoV-2 infection and COVID-19 vaccination, with over 30 different rashes identified post-infection, including morbilliform or maculopapular rashes, chilblains, and urticaria. Hair loss in the forms of alopecia areata and telogen effluvium has also been recorded. Post-vaccination cutaneous reactions occurred in 9% of larger cohort studies, more frequently with mRNA-based COVID-19 vaccines. These reactions included delayed large local reactions, local injection site reactions, urticarial eruptions, and morbilliform eruptions. Other reactions include herpes zoster reactivation, pernio/chilblains flare, erythema multiforme, bullous disease, hair loss, and psoriasis flare. The document emphasizes the role of dermatologists in evaluating these manifestations and promoting COVID-19 vaccination. It also highlights the disparities in vaccine distribution, with 19.4% of individuals in low-income countries having received one dose of the vaccine compared to 78.4% in high-income countries as of June 1, 2022.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community 25M Exploring Causes of Hair Loss: TE, Alopecia, or AGA?

      in General  226 upvotes 2 months ago
      The user is experiencing hair loss with possible causes including chronic telogen effluvium, diffuse alopecia areata, and androgenic alopecia. They have tried treatments like Nizoral shampoo, minoxidil, and finasteride, and are considering a biopsy for further clarity.

      community is there anything that stops hair loss?

      in Female  6 upvotes 1 year ago
      A user is experiencing rapid hair loss and has been diagnosed with telogen effluvium by multiple dermatologists, but doubts the diagnosis due to the severity and speed of the hair loss. They are considering various treatments like spironolactone, estradiol, and possibly finasteride, while also exploring the possibility of hormonal imbalances or autoimmune issues.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Similar Research

    6 / 1000+ results